Related Media Coverage on Executive Order

Conduent:  Administration Eyes Expanding HDHP Pre-Deductible Coverage to Chronic Disease Managment

 
Julia Zuckerman & Richard Stover

A recent draft executive order would direct the IRS to expand the list of preventive care services that an HDHP plan can cover before the participant or beneficiary has met the plan’s deductible.  Specifically, it would update the preventive care rules for HDHPs to include services or benefits, including medications, relating to care for chronic disease management.

 

Kaiser Health News:  Trump Plan Might Cut Expenses For Some Insured Patients With Chronic Needs

 
Michelle Andrews

Out-of pocket expenses could shrink under a Trump administration draft executive order that would change the Internal Revenue Service rules about what care can be covered before the deductible is met in plans linked to health savings accounts, or HSAs.

 

Modern Healthcare:  Draft Executive Order Would Enhance High-Deductible Coverage for Chronic Disease Care

 
Shelby Livingston

While all eyes were on Senate Republicans last week as they rushed to assemble their bill to repeal the Affordable Care Act, a draft version of a White House executive order surfaced that would allow patients enrolled in high-deductible health plans to access care for chronic conditions before they meet their deductible.

 

Inside Health Policy:  Leaked Draft Executive Order on Rx Prices Targets Plans, PBMs, Other Countries

A leaked draft of an alleged White House executive order on drug prices calls for value-based contracts, lower Medicare beneficiary out-of-pocket costs, drug rebate reforms, restricted hospital drug discounts, faster FDA approvals and higher prices in other countries.

 

Roll Call:  Draft Drug Price Order Focuses on Regulations, Trade

 
Joe Williams & Andrew Siddons

The Trump administration might seek to roll back regulations in pursuit of faster drug approvals, promoting drug competition and new payment models for federal health insurance programs, according to a draft executive order obtained by CQ Roll Call.

 

BioCentury:  Draft Executive Order Favors Pharma over PBMS, Hospitals

 
Steve Usdin

A draft executive order aimed at “reducing the cost of medical products and enhancing American biomedical innovation” includes provisions intended to cut PBMs’ revenues and to reform the 340B program in ways that would reduce costs to drug companies and reduce discounts available to hospitals.